Robert S. Rosenson
Icahn School of Medicine at Mount Sinai
H-index: 93
North America-United States
Top articles of Robert S. Rosenson
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Prediction of Venous Thromboembolism in Diverse Populations Using Machine Learning and Structured Electronic Health Records | Arteriosclerosis, Thrombosis, and Vascular Biology | Robert Chen Ben Omega Petrazzini Waqas A Malick Robert S Rosenson Ron Do | 2024/2 |
Monocyte-Mediated Thrombosis Linked to Circulating Tissue Factor and Immune Paralysis in COVID-19 | Arteriosclerosis, Thrombosis, and Vascular Biology | Sascha N Goonewardena Qinzhong Chen Ashley M Tate Olga G Grushko Dilna Damodaran | 2024/3/21 |
Persistence and Adherence to PCSK9 Inhibitor Monoclonal Antibodies Versus Ezetimibe in Real-World Settings | Advances in Therapy | Paul Muntner Lama Ghazi Jenna Jones Nafeesa Dhalwani Bharat Poudel | 2024/4/30 |
Quantification of LDL-cholesterol corrected for molar concentration of lipoprotein (a) | Cardiovascular Drugs and Therapy | Robert S Rosenson J Antonio G López Maria Laura Monsalvo You Wu Huei Wang | 2024/2 |
Artificial intelligence in preventive cardiology | Adham El Sherbini Robert S Rosenson Mahmoud Al Rifai Hafeez Ul Hassan Virk Zhen Wang | 2024/3/7 | |
Whole Blood Viscosity and Thromboembolic Events in Hospitalized Patients with COVID-19: Post hoc Analysis of the ATTACC/ACTIV-4a Trial | Thrombosis and Haemostasis | Daein Choi Joshua D Froess Patrick R Lawler Mathew D Neal Ryan Zarychanski | 2024/4/16 |
Competing Genetic Traits and Their Influence on LDL Cholesterol Concentration in Familial Hypercholesterolemia | Case Reports | Christopher Song Robert S Rosenson | 2024/1/17 |
Evinacumab Reduces Triglyceride-Rich Lipoproteins in Patients with Hyperlipidemia: A Post-Hoc Analysis of Three Randomized Clinical Trials | Cardiovascular Drugs and Therapy | Robert S Rosenson Daniel J Rader Shazia Ali Poulabi Banerjee Jennifer McGinniss | 2024/3/6 |
Plozasiran (ARO-APOC3) for Severe Hypertriglyceridemia: The SHASTA-2 Randomized Clinical Trial | JAMA cardiology | Daniel Gaudet Denes Pall Gerald F Watts Stephen J Nicholls Robert S Rosenson | 2024/4/7 |
Low-density lipoprotein cholesterol testing following myocardial infarction hospitalization among medicare beneficiaries | JACC: Advances | Lisandro D Colantonio Zhixin Wang Jenna Jones Nafeesa N Dhalwani Erin D Shannon | 2024/1/1 |
Heparin dose intensity and organ support-free days in patients hospitalized for COVID-19 | JACC: Advances | Lucas C Godoy Matthew D Neal Ewan C Goligher Mary Cushman Brett L Houston | 2024/3/1 |
MODERATE AND SEVERE HYPERTRIGLYCERIDEMIA AND MULTIORGAN DISEASE AMONG US ADULTS | Journal of the American College of Cardiology | Chen Gurevitz Ligong Chen Paul Muntner Robert S Rosenson | 2024/4/2 |
Validation of Signal Intensity Gradient from TOF-MRA for Wall Shear Stress by Phase-Contrast MR | Journal of Imaging Informatics in Medicine | Chan-Hyuk Lee Sang Hyuk Lee Hyo-Sung Kwak Yeong-Gon Kwak Robert S Rosenson | 2024/2/8 |
Muesli intake may protect against coronary artery disease: Mendelian randomization on 13 dietary traits | JACC: Advances | Joshua K Park Ben Omega Petrazzini Shantanu Bafna Áine Duffy Iain S Forrest | 2024/4/1 |
Inhibition of PCSK9 with evolocumab modulates lipoproteins and monocyte activation in high-risk ASCVD subjects | Atherosclerosis | Robert S Rosenson Ashley Tate Phyu Mar Olga Grushko Qinzhong Chen | 2024/5/1 |
Primary Prevention of Subclinical Atherosclerosis in Young Adults: JACC Review Topic of the Week | Ana Devesa Borja Ibanez Waqas A Malick Elizabeth O Tinuoye Jessica Bustamante | 2023/11/28 | |
Machine learning-based marker for coronary artery disease: derivation and validation in two longitudinal cohorts | The Lancet | Iain S Forrest Ben O Petrazzini Áine Duffy Joshua K Park Carla Marquez-Luna | 2023/1/21 |
Intensity of Lipid-Lowering Therapy Among Patients With Polyvascular Disease | JAMA Network Open | Benjamin E Peterson Deepak L Bhatt Christie M Ballantyne James A de Lemos Robert S Rosenson | 2023/3/1 |
Phenome-wide Mendelian randomization study of plasma triglyceride levels and 2600 disease traits | Elife | Joshua K Park Shantanu Bafna Iain S Forrest Áine Duffy Carla Marquez-Luna | 2023/3/29 |
Familial Hypercholesterolemia: Challenges for a High-Risk Population: JACC Focus Seminar 1/3 | Daein Choi Waqas A Malick Wolfgang Koenig Daniel J Rader Robert S Rosenson | 2023/4/25 |
